What is it about?

This study investigates whether methanolic extract of Spirulina platensis, a nutrient-rich blue-green microalga, can inhibit the growth of human triple-negative breast cancer cells (MDA-MB-231) and promote their death through apoptosis. It evaluates the extract’s cytotoxic and antioxidant properties, examines changes in cell morphology and DNA integrity, and compares its effects on cancer cells with those on normal cells. The study explores the potential of Spirulina as a natural source of bioactive compounds for future breast cancer research.

Featured Image

Why is it important?

This study is important because triple-negative breast cancer is an aggressive cancer subtype with limited targeted treatment options. Investigating Spirulina platensis may help identify naturally derived compounds that inhibit cancer cell growth and trigger programmed cell death (apoptosis). By examining its effects on cancer cells and comparing them with non-cancerous cells, the study may provide preliminary evidence for developing safer, nature-inspired anticancer strategies, although further mechanistic and clinical research is needed.

Perspectives

The findings may support further investigation of Spirulina platensis as a source of bioactive compounds for breast cancer research. Future studies should identify the active constituents, clarify the molecular mechanisms involved in apoptosis, assess selectivity toward cancer cells, and validate the results in animal models before considering potential therapeutic applications.

Prof. Rumana Ahmad
Era's Lucknow Medical College and Hospital

Read the Original

This page is a summary of: Apoptotic and Anti-Proliferative Potential of Spirulina platensis Methanolic Extract Against the Human Breast Cancer Cell Line MDA-MB-231: A Step Towards Functional Cancer Therapy, Anti-Cancer Agents in Medicinal Chemistry, August 2026, Bentham Science Publishers,
DOI: 10.2174/0118715206383642251105064036.
You can read the full text:

Read

Contributors

The following have contributed to this page